December 19, 2024

Vertex Dives 12% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug

business people have a meeting about company statistics

Vertex stock plummeted Thursday after the company's pain drug proved it's no better than a placebo in patients with lower back and hip pain.

OK